134 requirements-engineering-"https:"-"https:"-"https:"-"https:" "https:" positions at Virginia Tech
Sort by
Refine Your Search
-
Category
-
Field
-
and weekends as needed. Review Date July 9, 2026 Additional Information SEE MORE ABOUT WORKING IN VT ATHLETICS AT https://hokiesports.com/be-a-hokie The successful candidate will be required to have a
-
Information Up to $50,000 Hours per week 40+. Nights and weekends as needed. Review Date 6/12/2026 Additional Information SEE MORE ABOUT WORKING IN VT ATHLETICS AT https://hokiesports.com/be-a-hokie
-
Information See more about working in VT Athletics at https://hokiesports.com/be-a-hokie The successful candidate will be required to have a criminal conviction check. About Virginia Tech Dedicated to its
-
weekends as needed. Review Date 8/12/2026 Additional Information SEE MORE ABOUT WORKING IN VT ATHLETICS AT https://hokiesports.com/be-a-hokie The successful candidate will be required to have a
-
. • Successful completion of a psychological assessment is required. Federal, State, Local Government, and Other Requirements: • Must be a U.S. citizen as required by Virginia Code Section 15.2-1705. • Must
-
. • Successful completion of a psychological assessment is required. Federal, State, Local Government, and Other Requirements: • Must be a U.S. citizen as required by Virginia Code Section 15.2-1705. • Must
-
starting date is October 2025. More information about our activities and group composition can be found on the group’s webpage: https://boer.phys.vt.edu Required Qualifications - All candidates must
-
per week 40+. Nights and weekends as needed. Review Date 7/22/26 Additional Information SEE MORE ABOUT WORKING IN VT ATHLETICS AT https://hokiesports.com/be-a-hokie The successful candidate will be
-
letters should be sent in confidence to Isaacson, Miller: https://www.imsearch.com/open-searches/virginia-tech/president Greg Esposito, Julie Filizetti, Raul Bernal, Kristen Andersen, Gabrielle Nayer, and Victoria Castillo Isaacson, Miller
-
AML. We integrate multi-omics profiling of patient primary samples with iPSC, organoid, and mouse models to define disease mechanisms and identify therapeutic vulnerabilities. Lab website: https